<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-T68DCS4W/995fd61d-0bf2-4b0a-8bb4-c3b266bafba6/PDF"><dcterms:extent>659 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-T68DCS4W/593b0508-128a-4322-b001-8c271ed95e30/TEXT"><dcterms:extent>28 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2022-2025"><edm:begin xml:lang="en">2022</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-T68DCS4W"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-UCB4A42Q" /><dcterms:issued>2025</dcterms:issued><dc:creator>Razpotnik, Saša</dc:creator><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">str. 32-36</dc:format><dc:identifier>COBISSID_HOST:248500483</dc:identifier><dc:identifier>ISSN:2820-5014</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-T68DCS4W</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Fakulteta za farmacijo, ŠSSFD</dc:publisher><dcterms:isPartOf xml:lang="sl">Placebo</dcterms:isPartOf><dc:subject xml:lang="en">antibiotic treatment</dc:subject><dc:subject xml:lang="en">chlamydia</dc:subject><dc:subject xml:lang="sl">gonoreja</dc:subject><dc:subject xml:lang="en">gonorrhoea</dc:subject><dc:subject xml:lang="sl">klamidijska okužba</dc:subject><dc:subject xml:lang="sl">nove terapije</dc:subject><dc:subject xml:lang="en">novel therapies</dc:subject><dc:subject xml:lang="en">pathophysiology of sexually transmitted bacterial infections</dc:subject><dc:subject xml:lang="sl">patofiziologija spolno prenosljivih bakterijskih okužb</dc:subject><dc:subject xml:lang="en">sexually transmitted bacterial infections</dc:subject><dc:subject xml:lang="sl">sifilis</dc:subject><dc:subject xml:lang="sl">Spolne bolezni</dc:subject><dc:subject xml:lang="sl">spolno prenosljive bakterijske bolezni</dc:subject><dc:subject xml:lang="en">syphilis</dc:subject><dc:subject xml:lang="sl">Zdravljenje</dc:subject><dc:subject xml:lang="sl">zdravljenje z antibiotiki</dc:subject><dcterms:temporal rdf:resource="2022-2025" /><dc:title xml:lang="sl">Pregled bakterijskih spolno prenosljivih bolezni (gonoreja, sifilis, klamidijska okužba)| splošno o dermatoveneroloških boleznih|</dc:title><dc:description xml:lang="sl">Syphilis, gonorrhoea, and chlamydia are key representatives of bacterial sexually transmitted diseases and the treatment of such diseases is becoming more and more challenging due to the emergence of antimicrobial resistance to established therapies. The consequences of inefficient treatment can be extremely debilitating to the affected (the development of neurosyphilis, cardiosyphilis, dementia, infertility, ectopical pregnancy), and can be harmful to congenitally infected infants (underdeveloped immune system, greater risk of complications, blindness due to conjunctival infection). Due to the potentially severe nature of the infections it is crucial that we establish a good understanding of their pathophysiology, which can enable further research, discovery and development of effective and innovative therapies, that exceed the established antibiotic treatments</dc:description><dc:description xml:lang="sl">Sifilis, gonoreja in klamidijska okužba spadajo med bakterijske spolno prenosljive bolezni, ki zaradi možnosti razvoja večkratne odpornosti proti antibiotikom predstavljajo vedno večji izziv za svetovno zdravstvo. Posledice neustreznega zdravljenja so lahko za pacienta izjemno škodljive (razvoj nevrosifilisa, kardiosifilisa, demence, neplodnosti, ektopičnih zanositev), prav tako lahko vodijo v ogroženost kongenitalno okuženih novorojenčkov (manj razvit imunski sistem, večja možnost komplikacij, slepota zaradi konjunktivalnih okužb). Zaradi resnosti okužb in njihovih zapletov je pomembno, da razumemo patofiziološke mehanizme njihovega razvoja, kar nam lahko omogoča odkritje in razvoj novih učinkovitih in inovativnih terapij, ki presegajo ustaljeno zdravljenje z antibiotiki</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-T68DCS4W"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-T68DCS4W" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-T68DCS4W/995fd61d-0bf2-4b0a-8bb4-c3b266bafba6/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:dataProvider xml:lang="en">National and University Library of Slovenia</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-T68DCS4W/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-T68DCS4W" /></ore:Aggregation></rdf:RDF>